These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 3076714)
1. Studies on canine leishmaniasis control. 1. Evolution of infection of different clinical forms of canine leishmaniasis following antimonial treatment. Mancianti F; Gramiccia M; Gradoni L; Pieri S Trans R Soc Trop Med Hyg; 1988; 82(4):566-7. PubMed ID: 3076714 [TBL] [Abstract][Full Text] [Related]
2. Studies on canine leishmaniasis control. 2. Effectiveness of control measures against canine leishmaniasis in the Isle of Elba, Italy. Gradoni L; Gramiccia M; Mancianti F; Pieri S Trans R Soc Trop Med Hyg; 1988; 82(4):568-71. PubMed ID: 3256109 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of an immunochemotherapeutic protocol constituted of N-methyl meglumine antimoniate (Glucantime) and the recombinant Leish-110f + MPL-SE vaccine to treat canine visceral leishmaniasis. Miret J; Nascimento E; Sampaio W; França JC; Fujiwara RT; Vale A; Dias ES; Vieira E; da Costa RT; Mayrink W; Campos Neto A; Reed S Vaccine; 2008 Mar; 26(12):1585-94. PubMed ID: 18328956 [TBL] [Abstract][Full Text] [Related]
4. Leishmania infantum infection rates in Phlebotomus perniciosus fed on naturally infected dogs under antimonial treatment. Gradoni L; Maroli M; Gramiccia M; Mancianti F Med Vet Entomol; 1987 Oct; 1(4):339-42. PubMed ID: 2979550 [TBL] [Abstract][Full Text] [Related]
5. Comparative efficacy of meglumine antimoniate and aminosidine sulphate, alone or in combination, in canine leishmaniasis. Oliva G; Gradoni L; Cortese L; Orsini S; Ciaramella P; Scalone A; de Luna R; Persechino A Ann Trop Med Parasitol; 1998 Mar; 92(2):165-71. PubMed ID: 9625912 [TBL] [Abstract][Full Text] [Related]
6. Decreased sensitivity to meglumine antimoniate (Glucantime) of Leishmania infantum isolated from dogs after several courses of drug treatment. Gramiccia M; Gradoni L; Orsini S Ann Trop Med Parasitol; 1992 Dec; 86(6):613-20. PubMed ID: 1304703 [TBL] [Abstract][Full Text] [Related]
7. Evolution of serum albumin/globulin ratio after antimonial therapy in canine leishmaniasis. Amusategui I; Sainz A; Tesouro MA Ann N Y Acad Sci; 1998 Jun; 849():447-9. PubMed ID: 9668510 [No Abstract] [Full Text] [Related]
8. Leishmania infantum-specific IgG, IgG1 and IgG2 antibody responses in healthy and ill dogs from endemic areas. Evolution in the course of infection and after treatment. Solano-Gallego L; Riera C; Roura X; Iniesta L; Gallego M; Valladares JE; Fisa R; Castillejo S; Alberola J; Ferrer L; Arboix M; Portús M Vet Parasitol; 2001 Apr; 96(4):265-76. PubMed ID: 11267753 [TBL] [Abstract][Full Text] [Related]
9. Value of Western blotting in the clinical follow-up of canine leishmaniasis. Fernández-Pérez FJ; Méndez S; de la Fuente C; Cuquerella M; Gómez MT; Alunda JM J Vet Diagn Invest; 1999 Mar; 11(2):170-3. PubMed ID: 10098690 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of meglumine antimoniate after administration of a multiple dose in dogs experimentally infected with Leishmania infantum. Valladares JE; Riera C; Alberola J; Gállego M; Portús M; Cristòfol C; Franquelo C; Arboix M Vet Parasitol; 1998 Feb; 75(1):33-40. PubMed ID: 9566092 [TBL] [Abstract][Full Text] [Related]
11. First report of the use of meglumine antimoniate for treatment of canine leishmaniasis in a pregnant dog. Spada E; Proverbio D; Groppetti D; Perego R; Grieco V; Ferro E J Am Anim Hosp Assoc; 2011; 47(1):67-71. PubMed ID: 21164165 [TBL] [Abstract][Full Text] [Related]
12. Canine leishmaniasis: clinical, parasitological and entomological follow-up after chemotherapy. Alvar J; Molina R; San Andrés M; Tesouro M; Nieto J; Vitutia M; González F; San Andrés MD; Boggio J; Rodriguez F Ann Trop Med Parasitol; 1994 Aug; 88(4):371-8. PubMed ID: 7979624 [TBL] [Abstract][Full Text] [Related]
13. Changes in the concentration of anti-Leishmania antibodies in saliva of dogs with clinical leishmaniosis after short-term treatment. Cantos-Barreda A; Escribano D; Cerón JJ; Tecles F; Bernal LJ; Martínez-Subiela S Vet Parasitol; 2018 Apr; 254():135-141. PubMed ID: 29656998 [TBL] [Abstract][Full Text] [Related]
14. Effects of antimonial therapy for canine leishmaniasis on antibody titer. Amusategui I; Sainz A; Tesouro MA Ann N Y Acad Sci; 1998 Jun; 849():444-6. PubMed ID: 9668509 [No Abstract] [Full Text] [Related]
15. Serological and parasitological follow-up in dogs experimentally infected with Leishmania infantum and treated with meglumine antimoniate. Riera C; Valladares JE; Gállego M; Aisa MJ; Castillejo S; Fisa R; Ribas N; Carrió J; Alberola J; Arboix M Vet Parasitol; 1999 Jul; 84(1-2):33-47. PubMed ID: 10435789 [TBL] [Abstract][Full Text] [Related]
16. Specific IgG1 and IgG2 antibody responses of dogs to Leishmania infantum and other parasites. Deplazes P; Smith NC; Arnold P; Lutz H; Eckert J Parasite Immunol; 1995 Sep; 17(9):451-8. PubMed ID: 8552413 [TBL] [Abstract][Full Text] [Related]
17. Specific IgG1 and IgG2 antibody and lymphocyte subset levels in naturally Leishmania infantum-infected treated and untreated dogs. Bourdoiseau G; Bonnefont C; Hoareau E; Boehringer C; Stolle T; Chabanne L Vet Immunol Immunopathol; 1997 Oct; 59(1-2):21-30. PubMed ID: 9437823 [TBL] [Abstract][Full Text] [Related]
18. Early reduction of Leishmania infantum-specific antibodies and blood parasitemia during treatment in dogs with moderate or severe disease. Solano-Gallego L; Di Filippo L; Ordeix L; Planellas M; Roura X; Altet L; Martínez-Orellana P; Montserrat S Parasit Vectors; 2016 May; 9(1):235. PubMed ID: 27160317 [TBL] [Abstract][Full Text] [Related]
19. Hepatic fibropoiesis in dogs naturally infected with Leishmania (Leishmania) infantum treated with liposome-encapsulated meglumine antimoniate and allopurinol. Castro RS; de Amorim IFG; Pereira RA; Silva SM; Pinheiro LJ; Pinto AJW; Azevedo EG; Demicheli C; Caliari MMV; Mosser DM; Michalick MSM; Frezard FJG; Tafuri WL Vet Parasitol; 2018 Jan; 250():22-29. PubMed ID: 29329619 [TBL] [Abstract][Full Text] [Related]
20. [Parasitological and immunological progress control during and after chemotherapy of canine leishmaniasis]. Deplazes P; Arnold P; Skaggs J; Gessler M Schweiz Arch Tierheilkd; 1992; 134(2):85-93. PubMed ID: 1566026 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]